Safety and Anti-Disease Activity of CHR-2797 (Tosedostat) in Elderly and/or Treatment Refractory Patients With Acute Myeloid Leukemia (AML) and Multiple Myeloma (MM)

This study has been completed.
Sponsor:
Information provided by:
Chroma Therapeutics
ClinicalTrials.gov Identifier:
NCT00689000
First received: May 29, 2008
Last updated: October 21, 2010
Last verified: October 2010